Why stocks rose and fell on Nov 6, 2026
89 stocks with notable moves: companies over $10B that moved more than 5%, plus the sharpest moves among smaller companies. For each — the day's headlines with a link to the source; if there was no news, the page says so. The strongest sector was Technology (+1.79%), the weakest Consumer Defensive (−1.46%).
Gainers · 72
- Market pulseKarman Holdings posts record Q3 FY2026 revenue $201.6M (+66% YoY), non-GAAP EPS $0.19 (+90% YoY), beats estimates, raises 2026 revenue and adjusted EBITDA guidance
- Business WireKarman Space & Defense Reports Third Quarter Fiscal Year 2026 Financial Results
- BenzingaKarman Holdings Q3 Adj. EPS $0.19 Beats $0.15 Estimate, Sales $201.623M Beat $194.697M Estimate
The trigger was the quarterly report: EPS +90% year over year, 26.2% above the estimate.
- Market pulseNo clear catalyst identified; FLY rebounds 10% premarket after Thursday’s analyst-and-sector-driven selloff
- Market pulseFirefly Aerospace signs three-year rocket engine, IP licensing and engineering support deal worth over $1.3B with AST SpaceMobile
- Business WireAST SpaceMobile to Build Own 20-Ton Rocket to Deploy BlueBird Satellites in Low Earth Orbit Using Miranda Engines from Firefly Aerospace
- Market pulseJFrog Ltd reports fiscal Q3 2026 results with non-GAAP EPS $0.32 (+45% YoY) and revenue $179.2M (+31% YoY), beats EPS and revenue estimates
- Market pulseJFrog beats Q3 estimates as cloud revenue accelerates 60% and management again raises 2026 outlook
- BenzingaJFrog Q3 Adj. EPS $0.32 Beats $0.23 Estimate, Sales $179.170M Beat $165.887M Estimate
The trigger was the quarterly report: EPS +45% year over year, 37.7% above the estimate.
- Market pulsenLIGHT Inc reports fiscal Q3 2026 results with non-GAAP EPS $0.16 (+100% YoY) and revenue $73.8M (+11% YoY), beats EPS and revenue estimates
- Market pulsenLIGHT posts Q3 2026 EPS $0.16 on revenue $73.8M, beating estimates, guides Q4 revenue $84M-$90M
- BenzinganLight Q3 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $73.763M Beat $68.150M Estimate
The trigger was the quarterly report: EPS +100% year over year, 242.9% above the estimate.
- Market pulseTransMedics beats Q3 estimates with non-GAAP EPS $0.51 (-23% YoY), revenue $203.0M (+41% YoY), raises 2026 revenue guidance to $764–$774M
- Market pulseTransMedics posts record Q3 revenue $203.0M (+41% YoY), beats estimates, raises 2026 guidance, outlines major 2027 growth catalysts
- PR NewswireTransMedics Reports Third Quarter 2026 Financial Results
The trigger was the quarterly report: EPS −23% year over year, 71.3% above the estimate.
- Market pulseIonQ beats fiscal Q3 2026 estimates with non-GAAP EPS -$0.29 (+92% YoY) and revenue $173.8M (+336% YoY), raises guidance above Wall Street expectations
- Market pulseIonQ beats fiscal Q3 2026 estimates and raises full-year 2026 revenue guidance to $505–$515 million, above Wall Street expectations
- Barrons.comIonQ Wants to Be the Nvidia of Quantum. Its Latest Numbers Back Up the Swagger.
The trigger was the quarterly report: EPS +92% year over year, 17.0% above the estimate.
- Market pulseOklo posts Q3 2026 loss $0.28 per share, affirms cash-burn guidance and $3.1B liquidity with Aurora startup targeted for 2028–2029
- Market pulseOklo beats Q3 2026 estimates with non-GAAP EPS -$0.22 (-10% YoY) and revenue $1.9M, affirms cash-burn guidance and $3.1B liquidity
- Business WireOklo, U.S. Forged Rings Partner to Advance Domestic Manufacturing for Future Aurora Powerhouse Deployments
The trigger was the quarterly report: EPS −10% year over year, 18.4% above the estimate.
- Market pulseFirefly’s $1.3 billion ASTS engine deal lifts LUNR 12% alongside space peers
- BenzingaWhy Is Intuitive Machines Stock Gaining Friday?
- Market pulseIREN Q1 2027 revenue falls 5% to $228.0M, misses estimates, delays >$4B ARR target to early 2027
- GlobeNewswireIREN Reports Q1 FY27 Results
- BlockspaceIREN AI Cloud revenue hits $200 million as $4 billion ARR target moves to January
- Market pulseEton beats Q3 2026 estimates with EPS $0.50 and revenue $57.9M, sharply raises 2026 outlook and hits long‑term targets early
- GlobeNewswireEton Pharmaceuticals Announces Preliminary ET-700 Pilot Study Results Evaluating Copper Absorption Inhibition and Gastrointestinal Tolerability
- GlobeNewswireEton Pharmaceuticals Reports Third Quarter 2026 Financial Results
The trigger was the quarterly report: EPS +2,550% year over year, 239.2% above the estimate.
- Market pulseIonQ earnings beat lifts Infleqtion 16% with quantum peers in session
- Market pulseIonQ’s record quarter and raised guidance lift Rigetti 15.5% with quantum peers
- Market pulseSeaport Buy upgrade after earnings selloff lifts SiTime nearly 10% in early pre-market
- Market pulseRosenblatt names SiTime top semiconductor pick, reiterates Buy with $900 target after stronger-than-expected margins and earnings
- BenzingaUBS Maintains Buy on SiTime, Lowers Price Target to $650
- Market pulseTech rebound and space-sector strength lift Rocket Lab 9% after Thursday’s 12% rout
- BenzingaRocket Lab Stock Pulls Out of a Nosedive Friday: What's Going On?
- BenzingaReported November 5, 2026: Rocket Lab Posts On X "Electron's 100th mission. It's almost time. "The Mountain God Rises" will carry a QPS-SAR satellite for @QPS_Inc to a 575km LEO from Launch Complex 1 no earlier than Saturday Nov 14. Launch window opens: 12:30am Eastern"
- Market pulseNo clear catalyst identified; Summit rebounds 10% ahead of November 14 FDA decision
- Market pulseNo clear catalyst identified; Summit rebounds 15% after earnings selloff as biotech rallies
- Market pulseRosenblatt cuts Coherent Corp price target on valuation multiple compression despite recent earnings beat and raised guidance
- Fiscal.AiCoherent Reports Fiscal Q1 2027 Results and Announces $20B Long-Term Agreement
- Fiscal.AiCoherent Corp. Enters Long-Term Supply Agreement for Indium Phosphide Substrates
- Market pulseAirbnb beats Q3 2026 estimates with EPS $3.16 (+43% YoY) and revenue $4.9B (+19% YoY), raises full-year outlook and guides Q4 revenue
- Market pulseAirbnb beats Q3 2026 estimates with EPS $3.16 (+43% YoY), revenue $4.9B, raises outlook as at least 13 brokerages lift targets
- PR NewswireAirbnb Announces Third Quarter 2026 Results
The trigger was the quarterly report: EPS +43% year over year, 10.8% above the estimate.
- Market pulseSector-wide AI rebound lifts Fabrinet 7.8% premarket after Thursday’s 14% share selloff
- Market pulseNo clear catalyst identified; AMD rebounds 6% as Nasdaq futures recover from AI rout
- Market pulseNo clear catalyst identified; AMD rebounds 7% with chip peers after Thursday’s rout
- Yahoo FinanceQualcomm, Micron, Sandisk, and AMD stocks sink, leading chip sector lower
- Market pulseAI data-center rebound lifts FTAI 10% after election fears drove two-day selloff
- Fiscal.AiMorgan Stanley Adjusts FTAI Aviation Price Target
- Market pulseBroad chip-sector relief rally lifts MACOM 8% premarket after Thursday’s steep earnings-day selloff
- Fiscal.AiTruist Adjusts PT on MACOM Technology Solutions to $310 From $375, Keeps Buy Rating
- BenzingaSusquehanna Maintains Neutral on MACOM Technology Solns, Lowers Price Target to $220
The trigger was the quarterly report: EPS +122% year over year, 4.6% above the estimate.
- Market pulseCloudflare beats Zacks Q3 2026 estimates with EPS $0.38 on $782.5M revenue, issues EPS guidance for Q4 and 2026
- Market pulseCloudflare posts record Q3 growth, pulls forward GAAP profitability target to Q4 2026 as RBC, Scotiabank cut targets on valuation
- BenzingaCloudflare Q3 Adj. EPS $0.38 Beats $0.34 Estimate, Sales $782.513M Beat $738.532M Estimate
The trigger was the quarterly report: EPS +41% year over year, 11.0% above the estimate.
- Market pulseQ3 beat, strong guidance and expanded buyback extend AppLovin's rally another 8% by midday
- Yahoo FinanceAppLovin stock soars after Q3 earnings, outlook beat
- Fiscal.AiPiper Sandler Adjusts AppLovin Price Target
- Market pulseVistra’s raised guidance sparks power-producer rebound, lifting NRG 8.8% during regular trading
- Market pulseMasTec’s $250 million buyback pivot extends rebound, lifting shares 9.6% during Friday trading
- Market pulseElanco Animal Health posts Q3 2026 non-GAAP EPS $0.27 (+42% YoY) on revenue $1.3B (+11% YoY), beating estimates and raising 2026 guidance
- Market pulseElanco beats Q3 with EPS $0.27 (+42% YoY), revenue $1.265B (+11% YoY), raises 2026 guidance on pet innovation growth
- PR NewswireElanco Animal Health Reports Third Quarter 2026 Results
The trigger was the quarterly report: EPS +42% year over year, 33.1% above the estimate.
- Market pulseH.C. Wainwright target hike and biotech rebound lift RVMD 8% after earnings selloff
- BenzingaHC Wainwright & Co. Maintains Buy on Revolution Medicines, Raises Price Target to $350
- Fiscal.AiHC Wainwright & Co. Maintains Buy Rating and Raises Price Target for Revolution Medicines
- Market pulseLam Research announces new $25 billion share repurchase authorization and declares a $0.33 per share quarterly dividend
- PR NewswireLam Research Corporation Announces $25 Billion Share Repurchase Authorization and Declares Quarterly Dividend
- Fiscal.AiLam Research Announces $25 Billion Share Repurchase Authorization and Quarterly Dividend
No news on Tempus AI today. The Healthcare sector moved +1.38% (median).
- Market pulseFriday AI-infrastructure rebound lifts nVent 9% after election-driven data-center rout across peers
- Market pulseNo clear catalyst identified; Intel rebounds 4.8% after Thursday’s 10.3% selloff in premarket
- Market pulseChip-sector stabilization after Thursday’s AI-regulation rout lifts Intel 5% in Friday premarket
- Yahoo FinanceIntel's stock crash shares an uncanny resemblance to its 2000 bust
- Market pulseIREN's strong AI-cloud results spark sector rebound, lifting Nebius 11% in premarket trading
- BenzingaJim Cramer Raises Red Flags Over CoreWeave, IREN and Nebius Data Center Expansion: 'These Are What I Am Concerned About'
- BenzingaWhy Is Nebius Stock Surging on Friday?
- Market pulseAI-sector rebound lifts Arista 6% premarket after Thursday’s technology rout and 11% plunge
- Fiscal.AiArista Networks 10% Stockholder Andreas Bechtolsheim Proposes Sale of 260,000 Shares
- Market pulseNo clear catalyst identified; CRDO rebounds with semiconductor peers after Thursday’s AI rout
- Market pulseBroad chip-sector rebound after Thursday’s AI rout lifts Credo 11.5% in pre-market
- Market pulseIamgold posts Q3 adjusted EPS $0.42, beating estimates, on revenue $856.5M, and exercises $525M option to cut Côté Gold royalty
- Newsfile Corp.IAMGOLD Reports Third Quarter 2026 Results
- BenzingaIamgold Q3 Adj. EPS $0.42 Misses $0.51 Estimate, Sales $856.500M Miss $886.405M Estimate
- Market pulseChip-sector rebound following Thursday’s election-driven rout lifts Lattice 8% into midday
No news on Talen Energy today. Its industry peers (Utilities - Independent Power Producers) that day: “Vistra’s raised guidance sparks power-producer rebound, lifting NRG 8.8% during regular trading”.
- Market pulseAST SpaceMobile signs $1.3B Firefly Aerospace engine deal to power new in-house 20-ton rocket for BlueBird satellites
- Market pulseAST SpaceMobile details $1.3B Firefly deal for Miranda and Vira engines to power new Blacklift 20-ton rocket
- NewsfileKaplan Fox Urges Investors of AST SpaceMobile, Inc. (ASTS) to Seek a Leadership Role Before November 13, 2026
- Earnings WhispersCurtiss-Wright Beats And Raises For A Third Straight Quarter, But Defense Electronics And A 39% Share Slide Complicate The Story
- BenzingaGuggenheim Maintains Buy on Curtiss-Wright, Lowers Price Target to $674
- BenzingaPiper Sandler Maintains Neutral on Curtiss-Wright, Lowers Price Target to $544
- Market pulseAkamai beats Q3 2026 estimates with non-GAAP EPS $1.77 and revenue $1.12B, issues Q4 and full-year 2026 guidance
- GlobeNewswireAkamai Reports Third Quarter 2026 Financial Results
- BenzingaAkamai Techs Q3 Adj. EPS $1.77 Beats $1.67 Estimate, Sales $1.122B Beat $1.118B Estimate
The trigger was the quarterly report: EPS −5% year over year, 5.8% above the estimate.
- Market pulseKLA declares quarterly cash dividend of $0.23 per share, payable Dec. 1, 2026 to shareholders of record on Nov. 16, 2026.
- PR NewswireKLA Declares Regular Cash Dividend
- Fiscal.AiKLA Corporation Declares Quarterly Cash Dividend
- Market pulseNo clear catalyst identified; ASE ADR’s 9% gap reflects Taiwan-parity reset at NYSE open
- Market pulseReuters Nvidia-SPIL financing report and chip rebound lift ASE 6% despite intraday fade
- Market pulseBroad AI-infrastructure rebound after Thursday’s election-driven rout lifts CoreWeave 10.7% in Friday pre-market
- BenzingaJim Cramer Raises Red Flags Over CoreWeave, IREN and Nebius Data Center Expansion: 'These Are What I Am Concerned About'
- Fiscal.AiARK Invest Sells 412,666 Shares of CoreWeave
- Market pulseNo clear catalyst identified; ALAB rebounds 9% with Nasdaq futures after Thursday’s 20% selloff
- Market pulseBroad AI-chip rebound lifts Astera Labs 8.7% premarket after Thursday’s 19.6% rout
- Market pulseBernstein calls election selloff overblown, sending Quanta Services 8% higher in Friday rebound
- BenzingaLive ON CNBC, Jim Lebenthal Announces Bought Quanta Services
No news on Super Micro today. Its industry peers (Computer Hardware) that day: “AI-sector rebound lifts Arista 6% premarket after Thursday’s technology rout and 11% plunge”.
- Market pulseNo clear catalyst identified; biotech rebound lifts Roivant 6% ahead of Monday earnings
- Fiscal.AiRoivant Sciences Insider Sold Shares Worth $7,262,000
- Market pulseSeoul telecom rotation and ADR valuation catch-up lift SK Telecom 6% pre-market
- Business WireCoeur to Participate in RBC Capital Markets London Precious Metals Conference
- Market pulseNo clear catalyst identified; Marvell rebounds 8.5% after Thursday’s 16% selloff in early premarket
- Market pulseChip-sector rebound after Thursday’s AI rout lifts Marvell 7% in pre-market trading
- Business WireMarvell Technology, Inc. Announces Conference Call to Review Third Quarter of Fiscal Year 2027 Financial Results
- Market pulseNo clear catalyst identified; Lumentum tracks Marvell’s merger-linked 8% premarket rebound after Thursday’s rout
- Market pulseBroad chip-stock rebound after Thursday’s AI rout lifts Lumentum 10% in premarket trading
- Barrons.comWhy the Marvell and Lumentum Megadeal Has Both Stocks Headed for Historically Bad Weeks
- Market pulseSusquehanna cuts Qualcomm price target to $165 from $185 on concern lower-margin AI ASICs will pressure gross margins
- Yahoo FinanceQualcomm, Micron, Sandisk, and AMD stocks sink, leading chip sector lower
- BenzingaUBS Maintains Neutral on Qualcomm, Lowers Price Target to $180
- Market pulseSabesp reports third-quarter adjusted earnings of $0.30 per share on revenue of $1.97 billion
- Market pulseSabesp Q3 2026 results: non-GAAP EPS $0.06 (-51% YoY) on revenue $1.1B (+7% YoY), missing EPS and revenue estimates
- BenzingaCompanhia De Saneamento Q3 Adj. EPS $0.06 Down From $0.07 YoY, Sales $1.973B Beat $1.190B Estimate
The trigger was the quarterly report: EPS −21% year over year, 12.2% below the estimate.
- PR NewswireREGAL REXNORD ANNOUNCES PARTICIPATION AT UPCOMING CONFERENCES
- Market pulseNasdaq futures recovery and optical-peer rebound lift Ciena 8.9% pre-market after AI rout
- Market pulseNo clear catalyst identified; AI-infrastructure rebound lifts FIX 7.5% following Thursday’s rout
- Market pulseAI data-center rebound lifts Comfort Systems 7.7% after an election-driven two-day rout
No news on Nextpower today. The Technology sector moved +1.79% (median).
- Market pulseHumana beats Q3 2026 estimates, raises 2026 EPS guidance, highlights strong 2028 Medicare Advantage Star Ratings
- Market pulseHumana beats Q3 2026 estimates, raises 2026 EPS outlook, locks in 2028 Stars tailwind and 2027 Medicare Advantage margin rebound
- Barrons.comHumana Aced Key Medicare Ratings. Earnings Will Spotlight Other Cost Trends.
The trigger was the quarterly report: EPS −122% year over year, 30.1% above the estimate.
- Market pulseModerna posts surprise adjusted Q3 2026 profit on $1.3B revenue (+29% YoY), beating estimates and raising 2026 revenue growth outlook to 15%-25%
- Market pulseModerna posts surprise Q3 2026 profit on $1.3B revenue, raises 2026 growth outlook to 15–25% after melanoma trial win
- ACCESSWIREHealth Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
The trigger was the quarterly report: EPS +175% year over year, 134.7% above the estimate.
No news on Monolithic Power System today. Its industry peers (Semiconductors) that day: “Broad chip-sector relief rally lifts MACOM 8% premarket after Thursday’s steep earnings-day selloff”.
No news on Millicom International Cellular today. Its industry peers (Telecom Services) that day: “Seoul telecom rotation and ADR valuation catch-up lift SK Telecom 6% pre-market”.
No news on Insmed today. Its industry peers (Biotechnology) that day: “H.C. Wainwright target hike and biotech rebound lift RVMD 8% after earnings selloff”.
- Market pulseNo clear catalyst identified; Micron rebounds with chip peers after Thursday’s AI-led rout
- Market pulseChip-sector rebound after Thursday’s rout lifts Micron 6.7%, though shares fade after open
- Yahoo FinanceQualcomm, Micron, Sandisk, and AMD stocks sink, leading chip sector lower
No news on Li Auto today. The Consumer Cyclical sector moved −1.09% (median).
No news on Symbotic today. Its industry peers (Specialty Industrial Machinery) that day: “Oklo earnings beat sparks nuclear rebound, lifting NNE 15% in session”.
- Market pulseNo clear catalyst identified; ASML gains 5.8% as U.S. listing catches Amsterdam after late selloff
- Market pulseBroad semiconductor rebound after Thursday’s AI rout lifts ASML 6.3% in pre-market trading
Decliners · 17
- Market pulseiRhythm posts Q3 2026 EPS $0.82 (+612% YoY), revenue $221.6M, beats EPS but misses revenue estimates, raises 2026 revenue and adjusted EBITDA margin guidance
- GlobeNewswireiRhythm Holdings Announces Third Quarter 2026 Financial Results
- BenzingaiRhythm Technologies Q3 Adj. EPS $0.82 Beats $0.06 Estimate, Sales $221.592M Miss $222.451M Estimate
The trigger was the quarterly report: EPS −463% year over year, 5,923.4% below the estimate.
- Market pulseAMN Healthcare beats fiscal Q3 2026 estimates with non-GAAP EPS $1.16 (+197% YoY), revenue $717.3M (+13% YoY), but guides Q4 revenue down 10–12% YoY
- PR NewswireAMN HEALTHCARE ANNOUNCES THIRD QUARTER 2026 RESULTS
- BenzingaAMN Healthcare Services Q3 Adj. EPS $1.16 Beats $0.23 Estimate, Sales $717.272M Beat $649.540M Estimate
The trigger was the quarterly report: EPS +197% year over year, 406.2% above the estimate.
- Market pulseBlackLine posts Q3 2026 non-GAAP EPS $0.64 (+25% YoY), revenue $193.4M (+8% YoY), beats EPS but misses revenue, issues Q4 and 2026 guidance
- GlobeNewswireBlackLine Announces Third Quarter Financial Results
- BenzingaBlackLine Q3 Adj. EPS $0.64 Beats $0.63 Estimate, Sales $193.396M Miss $194.155M Estimate
The trigger was the quarterly report: EPS +25% year over year, 1.8% above the estimate.
- Market pulseOpendoor posts Q3 2026 revenue $1.02B (+12% YoY), misses revenue estimates, guides Q4 revenue growth of at least 40%
- GlobeNewswireOpendoor Reports Third Quarter 2026 Financial Results
- BenzingaOpendoor Technologies Q4 Revenue expected to be more than $1.030B vs $1.116B Est
- Market pulseDraftKings misses Q3 2026 estimates with non-GAAP EPS $-0.94, revenue $1.3B, cuts 2026 outlook and issues 2027 EBITDA forecast below estimates
- Market pulseDraftKings slashes 2026 EBITDA guidance to $175M–$275M to fund predictions, reiterates 2027 outlook for $7.35–$7.75B revenue and $800M–$1B EBITDA
- Business WireDraftKings Reports Third Quarter Revenue Growth of 16%
The trigger was the quarterly report: EPS −81% year over year, 129.1% below the estimate.
- Market pulseHelios Technologies Q3 2026 non-GAAP EPS $0.80 (+11% YoY), revenue $229.7M (+4% YoY) beat estimates as company raises 2026 sales guidance
- Market pulseHelios posts record Q3 2026 as adjusted EPS $0.80 and revenue $229.7M beat guidance, raises 2026 sales outlook to $895–$902M
- BenzingaHelios Technologies Q3 Adj. EPS $0.80 Beats $0.76 Estimate, Sales $229.700M Beat $220.359M Estimate
The trigger was the quarterly report: EPS +11% year over year, 5.9% above the estimate.
- Market pulseAxon Q3 2026 non-GAAP EPS $1.72 on $908.6M revenue, misses estimates, cuts 2026 revenue and FCF outlook on Dedrone delays
- Market pulseAxon faces sharp Wall Street price target cuts after weak Q3 results and reduced guidance
- PR NewswireAxon reports record Q3 2026 revenue of $909 million, up 28% year over year
The trigger was the quarterly report: EPS +47% year over year, 8.8% below the estimate.
- Market pulseAtlassian beats fiscal Q1 2027 estimates but guides for slower fiscal 2027 subscription ARR and revenue growth
- Market pulseAtlassian beats fiscal Q1 2027 estimates with strong AI-driven growth, but guides to slower cloud and subscription ARR growth
- BenzingaAtlassian Q1 Adj. EPS $1.65 Beats $1.44 Estimate, Sales $1.772B Beat $1.711B Estimate
The trigger was the quarterly report: EPS +59% year over year, 14.9% above the estimate.
- Market pulseHalozyme projects CMS Medicare Drug Price Negotiation Program rule will have zero to minimal impact on ENHANZE royalties through at least 2035
- Market pulseHalozyme says FDA grants accelerated approval to ENHANZE-enabled RYBREVANT FASPRO for recurrent or metastatic head and neck squamous cell carcinoma
- PR NewswireHALOZYME REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
The trigger was the quarterly report: EPS +39% year over year, 3.7% above the estimate.
- Market pulseNatera posts Q3 adjusted loss of $0.39 per share, missing forecasts, as revenue beats expectations at $794M and 2026 guidance set at $3.01–$3.04B
- Market pulseNatera raises 2026 guidance and targets $6B 2029 revenue as MRD growth drives strong Q3 momentum
- BenzingaNatera Raises FY2026 Sales Guidance from $2.850B-$2.910B to $3.005B-$3.035B vs $2.907B Est
The trigger was the quarterly report: EPS +34% year over year, 49.4% below the estimate.
- Market pulseMicrochip Technology beats fiscal Q2 2027 estimates with non-GAAP EPS $0.97 (+177% YoY) on revenue $1.6B (+42% YoY)
- Market pulseMicrochip Technology beats fiscal Q2 2027 estimates with non-GAAP EPS $0.97 on $1.62B revenue, guides Q3 EPS to $0.87–$0.95
- GlobeNewswireMicrochip Technology Announces Financial Results for Second Quarter of Fiscal Year 2027
- Market pulseCharter posts Q3 $2.4B loss on franchise impairment as internet subscriber declines worsen
- Market pulseCharter launches major cost-cutting overhaul targeting $2B in savings as broadband losses persist and Cox integration ramps
- BenzingaAirbnb, Charter Communications and 3 Stocks to Watch Heading Into Friday
The trigger was the quarterly report: EPS −346% year over year, 329.4% below the estimate.
- Market pulseSofter 2027 growth outlook extends Insulet’s post-earnings reversal, driving shares down 6.8%
- BenzingaCitigroup Maintains Neutral on Insulet, Raises Price Target to $170
- BenzingaJP Morgan Maintains Neutral on Insulet, Raises Price Target to $170
No news on Dexcom today. The Healthcare sector moved +1.38% (median).
No news on Centene today. The Healthcare sector moved +1.38% (median).
No news on Somnigroup International today. The Consumer Cyclical sector moved −1.09% (median).
Headlines link to their sources. We do not copy article text.